Klivira
Request demo

Navigating Mastectomy Prior Authorization for Gastroenterology Co-Management

Efficiently managing Mastectomy prior authorization for gastroenterology patients requires a unified approach to complex medical necessity criteria and diverse payer requirements across specialties.

While mastectomy primarily falls under surgical oncology, patients often present with significant comorbidities, including chronic gastrointestinal conditions. For health systems and GI practices, coordinating prior authorizations for a patient undergoing mastectomy while also managing ongoing gastroenterology care presents unique administrative challenges. Klivira addresses this by centralizing PA workflows, ensuring seamless approval processes for both high-cost surgical procedures and chronic GI treatments.

The Intersecting Needs of Mastectomy and Gastroenterology Patients

Patients requiring mastectomy frequently have co-existing conditions managed by gastroenterology, such as inflammatory bowel disease (IBD), hepatitis, or complex functional GI disorders. This necessitates a coordinated approach to prior authorization, where the administrative burden extends beyond the primary surgical procedure to encompass ongoing GI-related treatments and diagnostics.

Dual Prior Authorization Burdens for Complex Patient Journeys

Managing prior authorizations for a patient undergoing mastectomy involves distinct medical necessity reviews, often for surgical procedures and associated imaging. Simultaneously, their gastroenterology care may require separate PAs for high-cost biologics (e.g., Humira, Stelara, Entyvio), advanced imaging (MR enterography), or endoscopic procedures (capsule endoscopy). This dual burden demands a robust, integrated PA solution.

Critical Documentation for Mastectomy and Gastroenterology PAs

  • For Mastectomy: Comprehensive surgical consultation notes, pathology reports, diagnostic imaging results, and multidisciplinary tumor board recommendations.
  • For GI Biologics: Diagnosis confirmation (endoscopic, imaging, histologic), disease severity assessment (Mayo score for UC, CDAI for Crohn's), and documentation of prior conventional-therapy trials.
  • For GI Procedures: Clinical indication, prior workup (e.g., EGD for capsule endoscopy), and adherence to payer-specific medical necessity criteria.
  • For Hepatitis C DAAs: Genotype, fibrosis stage, and prior-treatment history as per AASLD guidelines.

Mitigating Denial Risks Across Surgical and GI Pathways

Common denial reasons for mastectomy PAs often relate to medical necessity documentation or site-of-service appropriateness. For gastroenterology, denials frequently stem from step therapy non-compliance for IBD biologics, missing disease severity scores, or insufficient screening documentation. Klivira's platform identifies these specific requirements, helping to prevent rejections across both care domains.

Klivira's Integrated Solution for Mastectomy and GI Prior Authorization

Klivira provides a comprehensive platform designed to manage the diverse prior authorization needs of complex patients. By integrating with EMRs and connecting to payer portals, our solution automates the submission and tracking of PAs for both high-cost surgical procedures like mastectomy and chronic, high-volume gastroenterology treatments.

Klivira Capabilities for Co-Managed Patient PA Workflows

  • Automated X12 278 and payer portal submissions for surgical procedures.
  • ACG/AGA-guideline-aware step therapy logic for IBD biologic sequencing.
  • Periodic re-authorization workflow support for chronic GI treatments.
  • EMR-driven data extraction to compile comprehensive documentation packets.
  • Intelligent routing for medical-vs-pharmacy benefit biologics, adapting to administration changes.

Frequently asked questions

How does Klivira differentiate between the documentation needed for a mastectomy PA versus a GI biologic PA?

Klivira's platform leverages distinct rules engines for surgical procedures and specialty medications. For mastectomy, it guides the collection of surgical notes, imaging, and pathology. For GI biologics, it focuses on disease severity scores, prior-therapy trials, and screening results, aligning with ACG/AGA guidelines.

Can Klivira manage ongoing prior authorizations for a patient with IBD while they are also undergoing breast cancer treatment?

Yes, Klivira is designed for chronic disease management, including the periodic re-authorization of IBD biologics. It tracks approval cycles and prompts for necessary documentation, ensuring continuous coverage even as the patient navigates other significant medical treatments like mastectomy.

What are common reasons for mastectomy PA denials that might impact a patient also seen by gastroenterology?

Mastectomy PA denials often cite insufficient medical necessity documentation, lack of prior conservative treatment trials (if applicable), or inappropriate site-of-service. These denials can delay critical care, impacting overall patient pathways, including concurrent GI treatment plans.

How does Klivira integrate with our EMR to pull data for both surgical and gastroenterology PAs?

Klivira utilizes SMART on FHIR and other integration methods to extract relevant patient data directly from your EMR. This includes surgical notes, diagnostic reports, medication histories, and lab results, compiling comprehensive PA requests for both mastectomy and GI-related services, reducing manual data entry.

Does Klivira support Da Vinci PAS standards for surgical prior authorizations?

Klivira actively supports industry standards like Da Vinci PAS for electronic prior authorization. This enables efficient, standardized communication with payers for surgical procedures, including mastectomy, streamlining the approval process and reducing administrative burden.

Related coverage

Other mastectomy prior authorization by payer

Other mastectomy prior authorization by specialty

Ready to automate prior auth for this procedure?

See how Klivira automates prior authorizations for your team.

Request a demo